US Stock MarketDetailed Quotes

BME Blackrock Health Sciences Trust

Watchlist
  • 39.110
  • -0.520-1.31%
Close Mar 10 16:00 ET
  • 39.500
  • +0.390+1.00%
Post 20:01 ET
545.35MMarket Cap23.99P/E (TTM)

Blackrock Health Sciences Trust Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q2)Jun 30, 2022
(FY)Dec 31, 2021
Assets
Cash cash equivalents and federal funds sold
13,259.36%71.34K
13,259.36%71.34K
87.95%1.14K
-82.87%534
-82.87%534
-99.91%606
224.79%3.12K
--3.12K
15.33%675.17K
-99.55%960
-Cash and cash equivalents
13,259.36%71.34K
13,259.36%71.34K
87.95%1.14K
-82.87%534
-82.87%534
-99.15%606
224.79%3.12K
--3.12K
-77.63%71.67K
-99.55%960
-Restricted cash and investments
--0
--0
--0
--0
--0
--0
--0
--0
127.74%603.5K
--0
Receivables
-25.98%1.2M
-25.98%1.2M
-13.75%3.44M
-31.81%1.62M
-31.81%1.62M
171.61%3.99M
-25.47%2.37M
--2.37M
2.95%1.47M
188.28%3.18M
Prepaid assets
--0
--0
--2.93K
--5.29K
--5.29K
----
----
----
--0
--0
-Available for sale securities
-2.01%30.77M
-2.01%30.77M
--19.94M
31.53%31.4M
31.53%31.4M
----
--23.87M
--23.87M
----
----
Derivative assets
----
----
----
-88.40%275
-88.40%275
--0
--2.37K
--2.37K
----
----
Deferred costs
--0
--0
10.53%84.6K
5.66%82.6K
5.66%82.6K
-24.22%76.54K
-14.56%78.17K
--78.17K
-2.08%101K
-27.84%91.5K
Total assets
29.94%774.59M
29.94%774.59M
2.88%625.28M
-1.65%596.1M
-1.65%596.1M
25.77%607.78M
-6.58%606.13M
--606.13M
-21.40%483.25M
17.00%648.81M
Liabilities
Payables
72.17%1.07M
72.17%1.07M
-27.00%1.25M
-30.34%621.39K
-30.34%621.39K
159.28%1.71M
-93.23%892.03K
--892.03K
-67.48%658.77K
2,137.02%13.17M
-Accounts payable
----
----
-67.28%172.78K
----
----
459,093.91%528.07K
-98.13%233.2K
--233.2K
-99.96%115
10,828.50%12.48M
-Other payable
72.17%1.07M
72.17%1.07M
-8.98%1.07M
-5.68%621.39K
-5.68%621.39K
79.15%1.18M
-4.27%658.83K
--658.83K
-61.44%658.66K
45.04%688.25K
Long term debt and capital lease obligation
150.57%152.06K
150.57%152.06K
----
1,978.29%60.69K
1,978.29%60.69K
79.47%96.19K
--2.92K
--2.92K
464.63%53.6K
----
Derivative product liabilities
-59.82%2.92M
-59.82%2.92M
9.36%6.73M
68.22%7.27M
68.22%7.27M
89.61%6.15M
-55.07%4.32M
--4.32M
-46.09%3.25M
23.54%9.62M
Other liabilities
--1.85M
--1.85M
-59.48%1.03M
----
----
379.69%2.54M
219.46%675.9K
--675.9K
22.75%529.38K
106.01%211.57K
Total liabilities
-24.36%6.03M
-24.36%6.03M
-14.41%9.02M
34.31%7.97M
34.31%7.97M
128.70%10.53M
-74.25%5.93M
--5.93M
-47.04%4.61M
167.38%23.04M
Shareholders'equity
Share capital
125.59%942.1M
125.59%942.1M
-2.39%417.62M
-1.57%417.62M
-1.57%417.62M
8.97%427.83M
8.65%424.3M
--424.3M
4.94%392.61M
15.16%390.51M
-common stock
125.59%942.1M
125.59%942.1M
-2.39%417.62M
-1.57%417.62M
-1.57%417.62M
8.97%427.83M
8.65%424.3M
--424.3M
4.94%392.61M
15.16%390.51M
Retained earnings
-201.77%-173.53M
-201.77%-173.53M
17.25%198.64M
-3.06%170.52M
-3.06%170.52M
96.91%169.42M
-25.24%175.9M
--175.9M
-62.92%86.04M
13.75%235.27M
Total stockholders'equity
30.68%768.57M
30.68%768.57M
3.18%616.26M
-2.01%588.14M
-2.01%588.14M
24.78%597.25M
-4.09%600.2M
--600.2M
-21.03%478.64M
14.62%625.77M
Total equity
30.68%768.57M
30.68%768.57M
3.18%616.26M
-2.01%588.14M
-2.01%588.14M
24.78%597.25M
-4.09%600.2M
--600.2M
-21.03%478.64M
14.62%625.77M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q2)Jun 30, 2022(FY)Dec 31, 2021
Assets
Cash cash equivalents and federal funds sold 13,259.36%71.34K13,259.36%71.34K87.95%1.14K-82.87%534-82.87%534-99.91%606224.79%3.12K--3.12K15.33%675.17K-99.55%960
-Cash and cash equivalents 13,259.36%71.34K13,259.36%71.34K87.95%1.14K-82.87%534-82.87%534-99.15%606224.79%3.12K--3.12K-77.63%71.67K-99.55%960
-Restricted cash and investments --0--0--0--0--0--0--0--0127.74%603.5K--0
Receivables -25.98%1.2M-25.98%1.2M-13.75%3.44M-31.81%1.62M-31.81%1.62M171.61%3.99M-25.47%2.37M--2.37M2.95%1.47M188.28%3.18M
Prepaid assets --0--0--2.93K--5.29K--5.29K--------------0--0
-Available for sale securities -2.01%30.77M-2.01%30.77M--19.94M31.53%31.4M31.53%31.4M------23.87M--23.87M--------
Derivative assets -------------88.40%275-88.40%275--0--2.37K--2.37K--------
Deferred costs --0--010.53%84.6K5.66%82.6K5.66%82.6K-24.22%76.54K-14.56%78.17K--78.17K-2.08%101K-27.84%91.5K
Total assets 29.94%774.59M29.94%774.59M2.88%625.28M-1.65%596.1M-1.65%596.1M25.77%607.78M-6.58%606.13M--606.13M-21.40%483.25M17.00%648.81M
Liabilities
Payables 72.17%1.07M72.17%1.07M-27.00%1.25M-30.34%621.39K-30.34%621.39K159.28%1.71M-93.23%892.03K--892.03K-67.48%658.77K2,137.02%13.17M
-Accounts payable ---------67.28%172.78K--------459,093.91%528.07K-98.13%233.2K--233.2K-99.96%11510,828.50%12.48M
-Other payable 72.17%1.07M72.17%1.07M-8.98%1.07M-5.68%621.39K-5.68%621.39K79.15%1.18M-4.27%658.83K--658.83K-61.44%658.66K45.04%688.25K
Long term debt and capital lease obligation 150.57%152.06K150.57%152.06K----1,978.29%60.69K1,978.29%60.69K79.47%96.19K--2.92K--2.92K464.63%53.6K----
Derivative product liabilities -59.82%2.92M-59.82%2.92M9.36%6.73M68.22%7.27M68.22%7.27M89.61%6.15M-55.07%4.32M--4.32M-46.09%3.25M23.54%9.62M
Other liabilities --1.85M--1.85M-59.48%1.03M--------379.69%2.54M219.46%675.9K--675.9K22.75%529.38K106.01%211.57K
Total liabilities -24.36%6.03M-24.36%6.03M-14.41%9.02M34.31%7.97M34.31%7.97M128.70%10.53M-74.25%5.93M--5.93M-47.04%4.61M167.38%23.04M
Shareholders'equity
Share capital 125.59%942.1M125.59%942.1M-2.39%417.62M-1.57%417.62M-1.57%417.62M8.97%427.83M8.65%424.3M--424.3M4.94%392.61M15.16%390.51M
-common stock 125.59%942.1M125.59%942.1M-2.39%417.62M-1.57%417.62M-1.57%417.62M8.97%427.83M8.65%424.3M--424.3M4.94%392.61M15.16%390.51M
Retained earnings -201.77%-173.53M-201.77%-173.53M17.25%198.64M-3.06%170.52M-3.06%170.52M96.91%169.42M-25.24%175.9M--175.9M-62.92%86.04M13.75%235.27M
Total stockholders'equity 30.68%768.57M30.68%768.57M3.18%616.26M-2.01%588.14M-2.01%588.14M24.78%597.25M-4.09%600.2M--600.2M-21.03%478.64M14.62%625.77M
Total equity 30.68%768.57M30.68%768.57M3.18%616.26M-2.01%588.14M-2.01%588.14M24.78%597.25M-4.09%600.2M--600.2M-21.03%478.64M14.62%625.77M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion----Unqualified Opinion----Unqualified Opinion
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
D.R. Horton
DHI
+0.40%
Lennar Corp
LEN
+0.02%
KB Home
KBH
-0.06%
Petroleo Brasileiro SA Petrobras
PBR
-1.46%
Ecopetrol
EC
-1.81%

Unlock the Full List